Portfolio of Coronavirus Treatment and Vaccine Stocks

The following table includes 21 coronavirus treatment and vaccine stocks. For more information about these stocks see These 19 companies are working on coronavirus treatments or vaccines — here’s where things stand.


21 Coronavirus Treatment and Vaccine Stocks

Stock Returns & Price Chart

Symbol

Recent Prices &
Annualized Return

AstraZenecaAZN
BioNTechBNTX
CytoDynCYDY
Dynavax TechnologiesDVAX
Emergent BioSolutionsEBS
Gilead SciencesGILD
GlaxoSmithKlineGSK
Heat BiologicsHTBX
Inovio PharmaceuticalsINO
Johnson & JohnsonJNJ
Mesoblast LimitedMESO
ModernaMRNA
NovavaxNVAX
PfizerPFE
Regeneron PharmaceuticalsREGN
Roche HoldingRHHBY
SanofiSNY
Takeda Pharmaceutical Company Ltd.TAK
Translate BioTBIO
VaxartVXRT
Vir BiotechnologyVIR
Price chart from Quandl as of most recent close.


21 Coronavirus Treatment and Vaccine Stocks

Stock Returns & Price Chart

Symbol

Recent Dividends

AstraZenecaAZN
BioNTechBNTX
CytoDynCYDY
Dynavax TechnologiesDVAX
Emergent BioSolutionsEBS
Gilead SciencesGILD
GlaxoSmithKlineGSK
Heat BiologicsHTBX
Inovio PharmaceuticalsINO
Johnson & JohnsonJNJ
Mesoblast LimitedMESO
ModernaMRNA
NovavaxNVAX
PfizerPFE
Regeneron PharmaceuticalsREGN
Roche HoldingRHHBY
SanofiSNY
Takeda Pharmaceutical Company Ltd.TAK
Translate BioTBIO
VaxartVXRT
Vir BiotechnologyVIR
Dividend chart data from Quandl as of most recent close.


To inspect the performance of the Coronavirus Treatment and Vaccine Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 16 stocks included in the portfolio computations are: AZN, CYDY, DVAX, EBS, GILD, GSK, HTBX, INO, JNJ, NVAX, PFE, REGN, RHHBY, SNY, TAK and VXRT. The current value of the portfolio assumes that $625.00 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 5 stocks excluded from the portfolio computations because of insufficient price data are: BNTX, MESO, MRNA, TBIO and VIR.

The current value of a $10,000 investment is $12,061. The percent return is 20.61%. The annualized return is 3.82%.



Return Summary for Coronavirus Treatment and Vaccine Stocks
Start DateMay-29-2015
Start Investment$10,000.00
End DateMay-28-2020
Current Value of Investment$12,060.59
Total Return20.61%
Annualized Return3.82%
Min DateMay-31-2019
Min Price$7,175.24
Max DateMay-28-2020
Max Price$12,060.59
# Monthly Prices61
Number Returns1,830
Number Profitable Returns816
Percent Profitable Returns44.59%
Number Unprofitable Returns1,014
Percent Unprofitable Returns55.41%
Profitable to Unprofitable Returns Ratio0.80
Use Stock Return Calculator to compute returns for individual stocks.


NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.

Use Stock Symbol and Stock Portfolio Finder to find a stock in a buyupside.com portfolio.

See Portfolio of Coronavirus Stocks.

See Portfolio of Coronavirus Lockdown Stocks.

See Portfolio of Coronavirus Vaccine Stocks

Related Portfolios

Portfolio of Medical Device Maker Stocks

Portfolio of Medical Diagnostic Stocks

Portfolio of Medical Equipment Stocks

Portfolio of Medical Instruments and Supplies Stocks

Portfolio of Medical Laboratory and Research Stocks

Portfolio of Telemedicine Stocks

Portfolio of Vaccine Stocks